Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Medhat Askar

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Haematologica|June 2, 2016
Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant ResearchAleksandr Lazaryan, Tao Wang, Stephen R Spellman, et al.
Viruses|April 27, 2024
No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE TrialsCharlotte Hedskog, Christoph D Spinner, Ulrike Protzer, et al.
Transplantation|January 3, 2020
Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working GroupCarrie A Schinstock, Roslyn B Mannon, Klemens Budde, et al.
Transplantation and Cellular Therapy|September 11, 2024
ASTCT Consensus Recommendations on Testing and Treatment of Patients with Donor-specific Anti-HLA AntibodiesPiyanuch Kongtim, Pongthep Vittayawacharin, Jun Zou, et al.
Transplantation and Cellular Therapy|March 15, 2021
Broad-Spectrum Antibiotics and Risk of Graft-versus-Host Disease in Pediatric Patients Undergoing Transplantation for Acute Leukemia: Association of Carbapenem Use with the Risk of Acute Graft-versus-Host DiseaseCaitlin W Elgarten, Yimei Li, Kelly D Getz, et al.
Blood|August 29, 2013
Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortalityJoseph Pidala, Tao Wang, Michael Haagenson, et al.
Blood|August 28, 2014
Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantationJoseph Pidala, Stephanie J Lee, Kwang Woo Ahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2025
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell TransplantationMonzr M Al Malki, Stephanie Bo-Subait, Brent Logan, et al.
American Journal of Human Genetics|February 1, 2020
Genome-wide Association Study Identifies HLA-DPB1 as a Significant Risk Factor for Severe Aplastic AnemiaSharon A Savage, Mathias Viard, Colm O'hUigin, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 1, 2018
Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting ReportAnat R Tambur, Patricia Campbell, Frans H Claas, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Haematologica|June 2, 2016
Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant ResearchAleksandr Lazaryan, Tao Wang, Stephen R Spellman, et al.
Viruses|April 27, 2024
No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE TrialsCharlotte Hedskog, Christoph D Spinner, Ulrike Protzer, et al.
Transplantation|January 3, 2020
Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working GroupCarrie A Schinstock, Roslyn B Mannon, Klemens Budde, et al.
Transplantation and Cellular Therapy|September 11, 2024
ASTCT Consensus Recommendations on Testing and Treatment of Patients with Donor-specific Anti-HLA AntibodiesPiyanuch Kongtim, Pongthep Vittayawacharin, Jun Zou, et al.
Transplantation and Cellular Therapy|March 15, 2021
Broad-Spectrum Antibiotics and Risk of Graft-versus-Host Disease in Pediatric Patients Undergoing Transplantation for Acute Leukemia: Association of Carbapenem Use with the Risk of Acute Graft-versus-Host DiseaseCaitlin W Elgarten, Yimei Li, Kelly D Getz, et al.
Blood|August 29, 2013
Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortalityJoseph Pidala, Tao Wang, Michael Haagenson, et al.
Blood|August 28, 2014
Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantationJoseph Pidala, Stephanie J Lee, Kwang Woo Ahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2025
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell TransplantationMonzr M Al Malki, Stephanie Bo-Subait, Brent Logan, et al.
American Journal of Human Genetics|February 1, 2020
Genome-wide Association Study Identifies HLA-DPB1 as a Significant Risk Factor for Severe Aplastic AnemiaSharon A Savage, Mathias Viard, Colm O'hUigin, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 1, 2018
Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting ReportAnat R Tambur, Patricia Campbell, Frans H Claas, et al.
Pageof 10